Who are eXoZymes, Inc.'s main suppliers?

eXoZymes, Inc. (EXOZ) key suppliers include: MDB-CAPITAL, THE-REGENTS, MDB Capital Holdings, LLC, Merck & Co., Inc., Merck & Co., Inc. and 2 more. View the full supplier network at chainsifter.com/chain/EXOZ.

Who are eXoZymes, Inc.'s major customers?

eXoZymes, Inc. (EXOZ) key customers include: Merck & Co., Inc., Merck & Co., Inc., Valero Energy Corporation, Valero Energy Corporation, SECURITIES-INVESTOR-PROTECTION-CORPORATION. View the full customer network at chainsifter.com/chain/EXOZ.

What sector is eXoZymes, Inc. in?

eXoZymes, Inc. (EXOZ) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

eXoZymes, Inc. Suppliers, Customers & Supply Chain (EXOZ)

7Suppliers

5Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

eXoZymes, Inc. (EXOZ) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships

5Distinct source URLs

6High confidence

0.784Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

eXoZymes, Inc. Suppliers

Ticker	Name	Confidence	Evidence
MDB-CAPITAL	MDB-CAPITAL	92%	the Company agreed to issue and sell, in a firm commitment underwritten offering (the “Offering”) an aggregate of 592,270 shares of common stock (the “Shares”), $0.000001 par value per share (the “Co…
THE-REGENTS	THE-REGENTS	92%	The payments made to the Regents in connection with our license agreement with the Regents, from 2019 to March 31, 2026, have aggregated $ 408,338
MDBH	MDB Capital Holdings, LLC	72%	Reciprocal relationship from MDBH graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from MDBH graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from MDBH g…
MRK	Merck & Co., Inc.	72%	● predictable, single-product precision without undesired by-products. The technology delivers >99% food/pharma-grade purity, simplifying formulation and regulatory readiness. Because the process run…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from EXOZ graph: ● predictable, single-product precision without undesired by-products. The technology delivers >99% food/pharma-grade …
VLO	Valero Energy Corporation	72%	● predictable, single-product precision without undesired by-products. The technology delivers >99% food/pharma-grade purity, simplifying formulation and regulatory readiness. Because the process run…
VLO	Valero Energy Corporation	72%	Reciprocal relationship from VLO graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from VLO graph: Reciprocal relationship from EXOZ graph: ● predictable, single-product precisi…

eXoZymes, Inc. Customers

Ticker	Name	Confidence	Evidence
MRK	Merck & Co., Inc.	72%	lly owned purpose built subsidiary – initially 100% owned by eXoZymes) If and when we identify a business opportunity (via a specific market application for one of our exozyme biosolutions), we plan …
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from MRK graph: Reciprocal relationship from EXOZ graph: lly owned purpose built subsidiary – …
VLO	Valero Energy Corporation	72%	lly owned purpose built subsidiary – initially 100% owned by eXoZymes) If and when we identify a business opportunity (via a specific market application for one of our exozyme biosolutions), we plan …
VLO	Valero Energy Corporation	72%	Reciprocal relationship from VLO graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from VLO graph: Reciprocal relationship from EXOZ graph: Reciprocal relationship from VLO grap…
SECURITIES-INVESTOR-PROTECTION-CORPORATION	SECURITIES-INVESTOR-PROTECTION-CORPORATION	62%	esent a transaction with a customer, the Company accounts for those aspects of the arrangement within the scope of ASC 606. If the Company concludes that some or all aspects of the arrangement are wi…

eXoZymes, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
EXOZ-DEBT	Debt stack $1.2M	90%	Market cache reports total debt of $1.2M.
EXOZ-DEBT-9416	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
EXOZ-DEBT-9415	Warrants outstanding: 11819	90%	xbrl warrant detail from xbrl 2025-12-31.

eXoZymes, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for eXoZymes, Inc..

eXoZymes, Inc. Ownership

Holder	Name	Confidence	Evidence
EXOZ-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 7 tracked holders.

eXoZymes, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
VLO	Valero Energy Corporation	100.00	1	['customer', 'supplier']
MRK	Merck & Co., Inc.	100.00	1	['customer', 'supplier']
MDBH	MDB Capital Holdings, LLC	100.00	1	['supplier']
DKS	DICK'S Sporting Goods, Inc.	50.00	2
CYTK	Cytokinetics, Incorporated	50.00	2
CBIH	Cannabis Bioscience International Holdings, Inc.	50.00	2
IMMP	Immutep Limited	50.00	2
EDSA	Edesa Biotech, Inc.	50.00	2
CORT	Corcept Therapeutics Incorporated	50.00	2
CHRS	Coherus Oncology, Inc.	50.00	2
DYN	Dyne Therapeutics, Inc.	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
GYRE	Gyre Therapeutics, Inc.	50.00	2
PAAPU	PLAINS ALL AMERICAN PIPELINE LP	50.00	2
BBVA	Banco Bilbao Vizcaya Argentaria, S.A.	50.00	2
REGN	Regeneron Pharmaceuticals, Inc.	50.00	2
EVFM	Evofem Biosciences, Inc.	50.00	2
ADAG	Adagene Inc.	50.00	2
ORANY	ORANGE	50.00	2
AZN	AstraZeneca PLC	50.00	2

eXoZymes, Inc. Supply Chain